trending Market Intelligence /marketintelligence/en/news-insights/trending/3eq-3lum9zejii-9xe0qha2 content esgSubNav
In This List

Dr. Reddy's COO to retire; former Teva executive named as replacement

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Dr. Reddy's COO to retire; former Teva executive named as replacement

India's Dr. Reddy's Laboratories Ltd. said its COO, Abhijit Mukherjee, will retire March 31.

Mukherjee, who served at the generic-drug maker for 15 years, will be replaced by Erez Israeli.

Israeli held several senior positions, including vice president of Asia operations and president and CEO of growth markets during his 23 years at Teva Pharmaceutical Industries Ltd.

He is also the former president and CEO of specialty chemicals-maker Enzymotec Ltd., which was acquired by Frutarom Industries Ltd. earlier this year.